The controversy stems from PhRMA's statement claiming the ad misrepresents the safety and efficacy of Hims and Hers' products and may violate marketing rules. Additionally, two US senators expressed ...

(Reuters) -Accenture has scrapped its global diversity and inclusion goals after an evaluation of the changing U.S. political landscape, according to an internal memo seen by Reuters on Friday.

"Our updated view is for no change in the fed funds rate during 2025 with it likely to remain in the 4.25 to 4.5% range.

Investing.com -- Shares of Varex Imaging (NASDAQ: VREX) Corporation (NASDAQ: VREX) dropped 19% as the company's first-quarter revenue fell short of Wall Street expectations. Despite posting a slight ...

S&P Global (NYSE: SPGI) has revised its outlook for O-I Glass (NYSE: OI) Inc. from positive to stable, citing marked underperformance in 2024 due to decreasing volumes and lower net prices. The ...